[1] – Galland, L. Magnesium, Stress and Neuropsychiatric Disorders. Great Smokies Diagnostic Laboratory, Asheville, N.C., USA
[2] – Vink R, Nechifor M, editors.. Magnesium in the Central Nervous System [Internet]. Adelaide (AU): University of Adelaide Press; 2011.
[3] – Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D. Magnesium Therapy for Periodic Leg Movements-related. Insomnia and Restless Legs Syndrome: An Open Pilot Study
[4] – USDA Agricultural Research Service, “Percentage of individuals meeting DRI – Magnesium – 32 per cent”
– Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of U.S. adults. J Nutr 2003;133: 2879-2882.
– Rude RK. Magnesium deficiency and diabetes mellitus: Causes and effects. Postgrad Med 1992; 92: 222-4.
– Iseri LT, Freed J, Bures AR. Magnesium deficiency and cardiac disorders. Am J Med 1975;58:837-46.
– Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998;5(1):24-7.
– Davalos Bichara M, Goldman, RD, MD. Magnesium for treatment of asthma in children. Canadian Family Physician. September 2009 vol. 55no. 9 887-889.
– George A. Eby , Karen L. Eby. Rapid recovery from major depression using magnesium treatment. Medical Hypotheses(2006)
– Seelig, Mildred MD, MPH. “Review and Hypothesis: Might Patients with the Chronic Fatigue Syndrome Have Latent Tetany of Magnesium Deficiency.” Journal of Chronic Fatigue Syndrome, Vol. 4(2) 1998
– Kubena KS, Durlach J. “Historical review of the effects of marginal intake of magnesium in chronic experimental magnesium deficiency.” Magnes Res.1990 Sep;3(3):219-26.
– Cox IM, Campbell MJ, Dowson D. “Red blood cell magnesium and chronic fatigue syndrome.” Lancet. 1991 Mar 30;337(8744):757-60.
– Pall, Martin. Explaining “Unexplained Illnesses.” CRC Press, 2007.
– Dr. Myhill discusses magnesium deficiency and treatment in CFS/ME patients. DrMyhill.co.
– Manuel y Keenoy, B, Moorkens, G, Vertommen, J, Noe, M, Neve, J, and De Leeuw, I. “Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium.” J Am Coll Nutr. 2000 Jun;19(3):374-82.
– Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. “Magnesium bioavailability from magnesium citrate and magnesium oxide.” J Am Coll Nutr. 1990 Feb;9(1):48-55.
– Sieverling C. “Dr. Cheney’s Basic Treatment Plan for Chronic Fatigue Syndrome.” ProHealth, 10/19/01.
[5] – Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-47 [PMID: 16808892 DOI:10.1016/j.abb.2006.05.007]
– Mather HM, Levin GE. Magnesium status in diabetes. Lancet 1979; 1: 924 [PMID: 86688 DOI: 10.1016/S0140-6736(79)91400-4]
– Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia 1992; 35: 77-79 [PMID: 1541384 DOI: 10.1007/BF00400855]
– Ramadass S, Basu S, Srinivasan AR. SERUM magnesium levelsas an indicator of status of Diabetes Mellitus type 2. Diabetes Metab Syndr 2015; 9: 42-45 [PMID: 25470649 DOI: 10.1016/ j.dsx.2014.04.024]
– Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940 [PMID: 7782801 DOI: 10.1016/0895-4356(94)00200-A]
– Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol 2012; 11: 23 [PMID: 22405520 DOI: 10.1186/1475-2840-11-23]
– Hashizume N, Mori M. An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med 1990; 29: 368-372 [PMID: 2273620 DOI: 10.2169/internalmedicine1962.29.368]
– Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, Rodríguez-Morán M. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004; 30: 253-258 [PMID: 15223977 DOI: 10.1016/ S1262-3636(07)70116-7]
– Wong ET, Rude RK, Singer FR, Shaw ST. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348-352 [PMID: 6829504]